missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human FGF-4, Animal-Free Recombinant Protein, PeproTech®
Click to view available options
Quantity:
250 μg
5 μg
50 μg
Unit Size:
250µg
50µg
5µg
Description
AF-100-31-1MG will be provided as 2 x 500 μg (AF-100-31-500UG). Recombinant Human FGF-4 is a 19.7 kDa protein consisting of 182 amino acid residues. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
Fibroblast growth factor 4 (FGF4) is a member of the fibroblast growth factor (FGF) family that possess broad mitogenic and cell survival activities and play key roles in growth and survival of stem cells during embryogenesis, tissue regeneration, and carcinogenesis. FGF4 was identified by its strong oncogenic transforming activity and is a potent angiogenic factor, expressed in several highly vascularized tumors and also in adult mouse testis, intestine, and brain. Studies on the mouse homolog suggests a function in bone morphogenesis and limb development through the sonic hedgehog (SHH) signaling pathway. Furthermore, FGF4 regulates neural progenitor cell proliferation and neuronal differentiation. Recent studies show a growth-promoting role for FGF4 in human embryonic stem cells and a putative feedback inhibition mechanism by a novel FGF4 splice isoform that may serve to promote differentiation at a later stages of development.
Specifications
Specifications
| Accession Number | P08620 |
| For Use With (Application) | Functional Assay |
| Format | Lyophilized |
| Formulation | protein with no preservative |
| Gene ID (Entrez) | 2249 |
| Molecular Weight (g/mol) | 19.7 kDa |
| Name | Human FGF-4, Animal-Free |
| Purification Method | HPLC, SDS-PAGE |
| Quantity | 50 μg |
| Regulatory Status | RUO |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction